Home > Products > Specialty & Industrial Chemicals > Specialty Chemicals > 8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON
8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON structure, CAS 283173-50-2

8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON

CAS Number283173-50-2

SynonymsKinome_3180; UNII-8237F3U7EH; AG-014699; Rucaparib; 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one; 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]6H-azepino[5,4,3-cd]indol-6-one; 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one

Molecular FormulaC19H18O1N3F1

Molecular Weight323.37

Purity

Density1.3±0.1 g/cm3

Boiling Point625.2±55.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-2176069 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 283173-50-2 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number283173-50-2
Catalog No.2A-2176069
Chinese Name瑞卡帕布
SynonymsKinome_3180; UNII-8237F3U7EH; AG-014699; Rucaparib; 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one; 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]6H-azepino[5,4,3-cd]indol-6-one; 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
Molecular FormulaC19H18O1N3F1
Molecular Weight323.37
Density1.3±0.1 g/cm3
Boiling Point625.2±55.0 °C at 760 mmHg
Storage Condition2-8℃
ApplicationRucaparib (AG-014699, PF-01367338) is a PARP inhibitor with a Ki of 1.4 nM for PARP1 and also has affinity for other PARP isoforms.
HTC2933990090
MDL NumberMFCD11977252
SMILESCNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1
InChI KeyHMABYWSNWIZPAG-UHFFFAOYSA-N
MSDSmsds/176563_1_283173_50_2.pdf
Use ofRucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1 in a cell-free assay, and also shows binding affinity to eight other PARP domains. Properties Name Rucaparib Synonym More Synonyms Rucaparib Biological Activity Description Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1 in a cell-free assay, and also shows binding affinity to eight other PARP domains. Related Catalog Research Areas >> Cancer PARP-1:1.4 nM (Ki) In Vitro Rucaparib is the most potent PARP inhibitor in enzyme assays (Ki, 1.4 nM), and a possible N-demethylation metabolite of AG14644[1]. The radio-sensitization by Rucaparib is due to downstream inhibition of activation of NF-κB, and is independent of SSB repair inhibition. Rucaparib could target NF-κB activated by DNA damage and overcome toxicity observed with classical NF-κB inhibitors without compromising other vital inflammatory functions[2]. Rucaparib inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilised D283Med cells[3]. Kinase Assay Inhibition of PARP activity in 5×103 D283Med cells is measured using various concentrations of Rucaparib (0-1 μM), compared with DMSO-only. Maximally stimulated PARP activity is measured in samples of permeabilised cells by immunologica. Cell Assay Medulloblastoma cell lines are seeded in 96-well plates at a density of 1×103, 3×103 and 3×103, respectively. At 24 hours (D384Med) or 48 hours (D283Med and D425Med) after seeding, the cells are exposed to various concentrations of temozolomide in the presence or absence of 0.4 μM Rucaparib. After 3 days (D425Med and D384Med) or 5 days (D283Med) of culture, cell viability is evaluated by a XTT cell proliferation kit assay. Cell growth is expressed as a percentage in relation to DMSO or 0.4 μM Rucaparib-alone controls. The concentration of temozolomide, alone or in combination with Rucaparib that inhibited growth by 50% (GI50) is calculated. The potentiation factor 50 (PF50) is defined as the ratio of the GI50 of temozolomide in the presence of Rucaparib to the GI50 of temozolomide alone. References [1]. Thomas HD, et al. Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. Mol Cancer Ther, 2007, 6(3), 945-956. [2]. Hunter JE, et al. NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene, 2012, 31(2), 251-264. [3]. Daniel RA, et al. Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699. Br J Cancer, 2010, 103(10), 1588-1596. [4]. Daniel RA, et al. Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. Clin Cancer Res, 2009, 15(4), 1241-1249. Chemical & Physical Properties Molecular Formula C19H18FN3O Exact Mass 323.143402 PSA 56.92000 Index of Refraction 1.649 InChIKey HMABYWSNWIZPAG-UHFFFAOYSA-N Storage condition 2-8℃ Safety Information HS Code 2933990090 Synthetic Route 4-(8-Fluoro-3,4... CAS#:283173-84-2 WD2000-012547 CAS#:283172-68-9 CAS#:283173-50-2 Literature: US6495541 B1, ; 4-(8-Fluoro-3,4... CAS#:283173-84-2 CAS#:283173-50-2 Literature: Organic Process Research and Development, , vol. 16, # 12 p. 1897 - 1904 Methyl 3-(2-(1,... CAS#:1408282-25-6 CAS#:283173-50-2 Literature: Organic Process Research and Development, , vol. 16, # 12 p. 1897 - 1904 Precursor & DownStream Precursor 7 CAS#:880160-69-0 [4-(8-fluoro-6-... CAS#:773059-19-1 Rucaparib inter... CAS#:283173-84-2 4-(8-Fluoro-3,4... CAS#:283172-68-9 WD2000-012547 DownStream 0
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA